CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2022. Read More.
Open Access Percentage
49%
Total
Publications
1.1K
Total Open
Publications
559
Total
Citations
31K
Open Access
Percentage
49%
Total
Publications
1.1K
Total Open
Publications
559
Total
Citations
31K
Breakdown
Publisher Open
20%
Both
20%
Other Platform Open
9%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
110
Hybrid 39%
178
No Guarantees 37%
165
Other Platform Open
Domain 68%
225
Institution 40%
132
Other Internet 26%
86
Preprint 9%
30
Public 9%
28
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 225 |
Europe PMC | Domain | 138 |
Paul Scherrer Institute - DORA PSI | Other Internet | 43 |
University College London - UCL Discovery | Institution | 25 |
arXiv | Preprint | 23 |
Semantic Scholar | Public | 22 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 20 |
DOI | Other Internet | 17 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 17 |
University of Zurich - Zurich Open Repository and Archive | Institution | 15 |